









Markets
/
Stocks
/
nasdaq-phge
/

Biomx Inc

PHGE

View Detailed Chart

0.432USD

+0.035+8.85%

Market hours （ET）Quotes delayed by 15 min

10.78MMarket Cap

LossP/E TTM



Biomx Inc

0.432

+0.035+8.85%

Overview Company Financials

Financials

Intraday

30m

Today

+8.85%

5 Days

+0.51%

1 Month

-1.91%

6 Months

-41.28%

Year to Date

-40.88%

1 Year

-76.98%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 2 analysts

BUY

Current Rating

18.500

Target Price

4565.83%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

552

Total

Median

Average

Company name

Ratings

Analysts

Biomx Inc

PHGE

CRISPR Therapeutics AG

CRSP

Intellia Therapeutics Inc

NTLA

Exact Sciences Corp

EXAS

Ionis Pharmaceuticals Inc

IONS

IQVIA Holdings Inc

IQV

...

111

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

15m

30m

15m

30m

D

Neutral

Sell(6)

Neutral(3)

Buy(4)

Indicators

Sell(3)

Neutral(3)

Buy(1)

Indicators

Value

Direction

MACD(12,26,9)

0.000

Neutral

RSI(14)

40.896

Neutral

STOCH(KDJ)(9,3,3)

26.144

Sell

ATR(14)

0.030

Low Volatility

CCI(14)

-73.111

Neutral

Williams %R

61.579

Sell

TRIX(12,20)

-0.331

Sell

StochRSI(14)

22.447

Buy

Moving Average

Sell(3)

Neutral(0)

Buy(3)

Indicators

Value

Direction

MA5

0.408

Buy

MA10

0.419

Buy

MA20

0.416

Buy

MA50

0.449

Sell

MA100

0.511

Sell

MA200

0.629

Sell

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

BiomX Inc., formerly Chardan Healthcare Acquisition Corp., is a microbiome company. The Company is focused on developing both natural and engineered phage therapies. It develops therapies to target and destroy bacteria that affect the appearance of skin, as well as harmful bacteria in chronic diseases, such as inflammatory bowel disease (IBD), primary sclerosing cholangitis (PSC) and cancer. The Company discovers and validates bacterial targets and customizes phage compositions against the targets. Its pipeline includes BX001, BX002 and BX003. BX001 is a product candidate that improves the appearance of acne-prone skin. BX002 is a customized phage cocktail that eradicates bacterial targets associated with the onset of IBD. BX003 is a customized phage cocktail developed against specific strains of Klebsiella pneumoniae (Kp).

Ticker SymbolPHGE

CompanyBiomx Inc

CEOMr. Jonathan Eitan Solomon

Websitehttps://www.biomx.com/